SUPPLEMENT

Q3 2023 — Income statement trends

Q3 2023PDF · 2 pages143 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q321 	Q421 	Q122 	Q222 	Q322 	Q422 	Q123 	Q223 	Q323
Revenues:
Clearing and transaction fees 	878.9 	949.3 	1,138.1 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3 	1,085.5
Market data and information services 	145.4 	142.1 	151.7 	151.7 	154.3 	153.2 	165.8 	163.1 	167.6
Other Revenue 	85.6 	55.9 	56.8 	60.9 	74.9 	73.2 	75.6 	78.8 	84.7
Total revenues 	1,109.9 	1,147.3 	1,346.6 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2 	1,337.8
Expenses:
Compensation and benefits 	198.6 	201.7 	185.2 	185.3 	189.6 	193.0 	204.5 	205.7 	205.5
Technology 	49.3 	45.8 	45.9 	45.9 	46.8 	50.0 	51.3 	53.3 	55.6
Professional fees and outside services 	45.2 	32.3 	31.8 	32.0 	35.1 	38.5 	38.3 	37.8 	32.2
Amortization of purchased intangibles 	59.0 	58.6 	58.4 	57.1 	55.5 	56.7 	56.8 	57.0 	57.2
Depreciation and amortization 	37.2 	35.9 	33.5 	33.0 	34.5 	33.9 	31.9 	32.3 	31.1
Licensing and other fee agreements 	57.6 	60.4 	80.9 	83.1 	83.6 	72.4 	84.7 	78.2 	79.5
Other expense 	49.3 	80.9 	51.8 	51.1 	43.9 	95.0 	60.4 	57.3 	56.5
Operating expenses 	496.2 	515.6 	487.5 	487.5 	489.0 	539.5 	527.9 	521.6 	517.6
Operating Income 	613.7 	631.7 	859.1 	749.7 	738.8 	668.3 	913.7 	838.6 	820.2
Operating Margin 	55% 	55% 	64% 	61% 	60% 	55% 	63% 	62% 	61%
Non-operating Income and Expense
Investment income 	145.8 	67.8 	73.1 	286.9 	686.2 	1,152.2 	1,357.7 	1,568.2 	1,272.5
Interest and other borrowing costs 	(41.8) 	(41.9) 	(42.5) 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2) 	(39.6)
Equity in net gains (losses) of unconsolidated subsidiaries 	66.4 	67.5 	73.3 	87.3 	76.5 	64.0 	78.2 	75.1 	76.8
Other non-operating income (expense) 	311.8 	74.2 	(46.7) 	(217.3) 	(581.1) 	(1,017.3) 	(1,152.8) 	(1,425.3) 	(1,155.6)
Non-operating income (expense) 	482.2 	167.6 	57.2 	117.0 	141.2 	159.0 	243.2 	177.8 	154.1
Income before income taxes 	1,095.9 	799.3 	916.3 	866.7 	880.0 	827.3 	1,156.9 	1,016.4 	974.3
Income taxes 	169.6 	174.1 	205.3 	204.2 	200.4 	189.4 	273.1 	238.8 	224.1
Net income 	926.3 	625.2 	711.0 	662.5 	679.6 	637.9 	883.8 	777.6 	750.2
Less: net income (loss) attributable to NCI 	(0.2) 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	926.5 	625.2 	711.0 	662.5 	679.6 	637.9 	883.8 	777.6 	750.2
Net Income Attributable to Common Shareholders of CME Group 	926.5 	613.3 	702.0 	654.1 	671.1 	629.9 	872.7 	767.8 	740.8
Effective Tax Rate 	15.5% 	21.8% 	22.4% 	23.6% 	22.8% 	22.8% 	23.6% 	23.5% 	23.0%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	2.59 	1.71 	1.96 	1.82 	1.87 	1.76 	2.43 	2.14 	2.06
Diluted EPS 	2.58 	1.71 	1.95 	1.82 	1.87 	1.75 	2.43 	2.14 	2.06
Weighted average number of common stock shares:
Basic Shares 	358,363 	358,582 	358,609 	358,641 	358,715 	358,885 	358,933 	358,940 	359,020
Diluted Shares 	358,988 	359,019 	359,180 	359,205 	359,288 	359,190 	359,313 	359,429 	359,619
Preferred Shares 	2,890 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q321 	Q421 	Q122 	Q222 	Q322 	Q422 	Q123 	Q223 	Q323
Revenues:
Clearing and transaction fees 	878.9 	949.3 	1,138.1 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3 	1,085.5
Market data and information services 	145.4 	142.1 	151.7 	151.7 	154.3 	153.2 	165.8 	163.1 	167.6
Other Revenue 	85.6 	55.9 	56.8 	60.9 	74.9 	73.2 	75.6 	78.8 	84.7
Total revenues 	1,109.9 	1,147.3 	1,346.6 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2 	1,337.8
Expenses:
Compensation and benefits 	191.1 	183.7 	182.8 	189.5 	189.1 	184.6 	192.8 	194.4 	193.5
Technology 	49.1 	45.6 	45.8 	45.9 	46.8 	50.0 	51.3 	53.3 	55.6
Professional fees and outside services 	26.5 	27.2 	30.3 	31.4 	35.1 	38.5 	38.3 	37.8 	32.2
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	36.7 	35.6 	33.5 	32.9 	33.8 	33.9 	31.9 	31.8 	31.1
Licensing and other fee agreements 	57.6 	60.4 	80.9 	83.1 	81.9 	72.4 	84.7 	78.2 	79.5
Other expense 	51.3 	76.5 	51.7 	59.6 	54.4 	84.5 	59.7 	56.2 	56.5
Operating expenses 	412.3 	429.0 	425.0 	442.4 	441.1 	463.9 	458.7 	451.7 	448.4
Operating Income 	697.6 	718.3 	921.6 	794.8 	786.7 	743.9 	982.9 	908.5 	889.4
Operating Margin 	63% 	63% 	68% 	64% 	64% 	62% 	68% 	67% 	66%
Non-operating Income and Expense
Investment income 	55.1 	58.2 	74.7 	299.5 	688.5 	1,147.1 	1,277.5 	1,564.0 	1,276.6
Interest and other borrowing costs 	(41.8) 	(41.9) 	(42.5) 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2) 	(39.6)
Equity in net gains (losses) of unconsolidated subsidiaries 	70.5 	78.7 	84.7 	98.2 	89.6 	76.2 	91.5 	88.6 	90.4
Other non-operating income (expense) 	(32.9) 	(33.0) 	(43.4) 	(218.5) 	(585.7) 	(1,023.3) 	(1,160.6) 	(1,429.9) 	(1,157.1)
Non-operating income (expense) 	50.9 	62.0 	73.5 	139.3 	152.0 	160.1 	168.5 	182.5 	170.3
Income before income taxes 	748.5 	780.3 	995.1 	934.1 	938.7 	904.0 	1,151.4 	1,091.0 	1,059.7
Income taxes 	174.3 	172.8 	228.9 	217.6 	219.6 	206.0 	269.1 	254.6 	241.7
Net income 	574.2 	607.5 	766.2 	716.5 	719.1 	698.0 	882.3 	836.4 	818.0
Less: net income (loss) attributable to NCI 	(0.2) 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	574.4 	607.5 	766.2 	716.5 	719.1 	698.0 	882.3 	836.4 	818.0
Net Income Attributable to Common Shareholders of CME Group 	574.4 	595.7 	756.6 	707.5 	710.0 	689.1 	871.1 	825.9 	807.9
Effective Tax Rate 	23.3% 	22.1% 	23.0% 	23.3% 	23.4% 	22.8% 	23.4% 	23.3% 	22.8%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.60 	1.66 	2.11 	1.97 	1.98 	1.92 	2.43 	2.30 	2.25
Diluted EPS 	1.60 	1.66 	2.11 	1.97 	1.98 	1.92 	2.42 	2.30 	2.25
Weighted average number of common stock shares:
Basic Shares 	358,363 	358,582 	358,609 	358,641 	358,715 	358,885 	358,933 	358,940 	359,020
Diluted Shares 	358,988 	359,019 	359,180 	359,205 	359,288 	359,190 	359,313 	359,429 	359,619
Preferred Shares 	- 	2,890 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 2 of 2 --